BlackRock Investment Management’s Cytosorbents Corp CTSO Stock Holding History

BlackRock Investment Management’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$21K	Hold	3,776	–	–	﹤0.01%	3370
2016 Q3	$24K	Hold	3,776	–	–	﹤0.01%	3338
2016 Q2	$17K	Buy	3,776 +1,185	+46%	+$5.16K	﹤0.01%	3427
2016 Q1	$10K	Hold	2,591	–	–	﹤0.01%	3604
2015 Q4	$14K	Buy	2,591 +178	+7%	+$1.21K	﹤0.01%	3551
2015 Q3	$15K	Hold	2,413	–	–	﹤0.01%	3528
2015 Q2	$15K	Buy	+2,413	New	+$16.4K	﹤0.01%	3551

Other funds holding CTSO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

MHP

Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

BlackRock Investment Management's CTSO Position: Q4 2016 in Review

BlackRock Investment Management held its Cytosorbents Corp (CTSO) position steady in Q4 2016 at 3,776 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #3370.

BlackRock Investment Management first reported a position in CTSO in Q2 2015 and has held it in 7 quarters since. The position peaked at $24K in Q3 2016. 38 funds tracked by Wall St. Rank hold CTSO as of Q4 2016.

BlackRock Investment Management held 3,776 shares of Cytosorbents Corp worth $21K as of Q4 2016.
BlackRock Investment Management left its Cytosorbents Corp share count unchanged in Q4 2016.
Cytosorbents Corp made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3370 holding.
BlackRock Investment Management first reported a position in Cytosorbents Corp in Q2 2015 and has held it in 7 quarters since.
BlackRock Investment Management's Cytosorbents Corp position peaked at $24K in Q3 2016.
38 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.